Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
6.90
-0.41 (-5.61%)
At close: Nov 20, 2026, 4:00 PM EST
6.99
+0.09 (1.25%)
After-hours: Nov 20, 2026, 7:59 PM EST
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 975 employees as of December 31, 2025. The number of employees increased by 137 or 16.35% compared to the previous year. That makes Iovance Biotherapeutics the 15,124th largest employer in the world and 2,184th in the United States.
Employees
975
Change (1Y)
137
Growth (1Y)
16.35%
Revenue / Employee
$388,701
Profits / Employee
-$226,190
Market Cap
3.19B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 975 | 137 | 16.35% |
| Dec 31, 2024 | 838 | 281 | 50.45% |
| Dec 31, 2023 | 557 | 54 | 10.74% |
| Dec 31, 2022 | 503 | 184 | 57.68% |
| Dec 31, 2021 | 319 | 78 | 32.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 562 |
| Xenon Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Viridian Therapeutics | 252 |
| Relay Therapeutics | 218 |
| Disc Medicine | 173 |
| Parabilis Medicines | 145 |
| Tango Therapeutics | 137 |
IOVA News
- 19 hours ago - Iovance downgraded to Neutral from Outperform at Mizuho - TheFly
- 19 hours ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 days ago - Iovance Biotherapeutics Transcript: Jefferies Global Healthcare Conference - Transcripts
- 8 days ago - Iovance Biotherapeutics to Present at Upcoming Conference - GlobeNewsWire
- 15 days ago - Iovance price target raised to $12 from $8 at Citizens - TheFly
- 15 days ago - Iovance price target raised to $19 from $18 at Barclays - TheFly
- 16 days ago - Iovance Biotherapeutics Earnings Call Transcript: Q3 2026 - Transcripts
- 16 days ago - Iovance Biotherapeutics Earnings release: Q3 2026 - Filings